Abemaciclib for Bone and Soft Tissue Sarcoma With Cyclin-Dependent Kinase (CDK) Pathway Alteration

NCT04040205 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

44

Enrollment

OTHER

Sponsor class

Conditions

Chondrosarcoma
Osteosarcoma
Soft Tissue Sarcoma

Interventions

DRUG: Abemaciclib

Sponsor

Medical College of Wisconsin